These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

346 related articles for article (PubMed ID: 24805308)

  • 1. Transitions between epithelial and mesenchymal states during cell fate conversions.
    Li X; Pei D; Zheng H
    Protein Cell; 2014; 5(8):580-91. PubMed ID: 24805308
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The function and regulation of mesenchymal-to-epithelial transition in somatic cell reprogramming.
    Shu X; Pei D
    Curr Opin Genet Dev; 2014 Oct; 28():32-7. PubMed ID: 25173869
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Incomplete cellular reprogramming of colorectal cancer cells elicits an epithelial/mesenchymal hybrid phenotype.
    Hiew MSY; Cheng HP; Huang CJ; Chong KY; Cheong SK; Choo KB; Kamarul T
    J Biomed Sci; 2018 Jul; 25(1):57. PubMed ID: 30025541
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tet and TDG mediate DNA demethylation essential for mesenchymal-to-epithelial transition in somatic cell reprogramming.
    Hu X; Zhang L; Mao SQ; Li Z; Chen J; Zhang RR; Wu HP; Gao J; Guo F; Liu W; Xu GF; Dai HQ; Shi YG; Li X; Hu B; Tang F; Pei D; Xu GL
    Cell Stem Cell; 2014 Apr; 14(4):512-22. PubMed ID: 24529596
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Epithelial-mesenchymal transition (EMT): A biological process in the development, stem cell differentiation, and tumorigenesis.
    Chen T; You Y; Jiang H; Wang ZZ
    J Cell Physiol; 2017 Dec; 232(12):3261-3272. PubMed ID: 28079253
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sequential introduction of reprogramming factors reveals a time-sensitive requirement for individual factors and a sequential EMT-MET mechanism for optimal reprogramming.
    Liu X; Sun H; Qi J; Wang L; He S; Liu J; Feng C; Chen C; Li W; Guo Y; Qin D; Pan G; Chen J; Pei D; Zheng H
    Nat Cell Biol; 2013 Jul; 15(7):829-38. PubMed ID: 23708003
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cell reprogramming into the pluripotent state using graphene based substrates.
    Yoo J; Kim J; Baek S; Park Y; Im H; Kim J
    Biomaterials; 2014 Sep; 35(29):8321-9. PubMed ID: 24996757
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ultrastructural visualization of the Mesenchymal-to-Epithelial Transition during reprogramming of human fibroblasts to induced pluripotent stem cells.
    Høffding MK; Hyttel P
    Stem Cell Res; 2015 Jan; 14(1):39-53. PubMed ID: 25506910
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cellular reprogramming: a small molecule perspective.
    Nie B; Wang H; Laurent T; Ding S
    Curr Opin Cell Biol; 2012 Dec; 24(6):784-92. PubMed ID: 22959962
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mesenchymal-epithelial transition in development and reprogramming.
    Pei D; Shu X; Gassama-Diagne A; Thiery JP
    Nat Cell Biol; 2019 Jan; 21(1):44-53. PubMed ID: 30602762
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Reprogramming during epithelial to mesenchymal transition under the control of TGFβ.
    Tan EJ; Olsson AK; Moustakas A
    Cell Adh Migr; 2015; 9(3):233-46. PubMed ID: 25482613
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Epithelial-to-Mesenchymal Transition: Epigenetic Reprogramming Driving Cellular Plasticity.
    Skrypek N; Goossens S; De Smedt E; Vandamme N; Berx G
    Trends Genet; 2017 Dec; 33(12):943-959. PubMed ID: 28919019
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Multiple targets of miR-302 and miR-372 promote reprogramming of human fibroblasts to induced pluripotent stem cells.
    Subramanyam D; Lamouille S; Judson RL; Liu JY; Bucay N; Derynck R; Blelloch R
    Nat Biotechnol; 2011 May; 29(5):443-8. PubMed ID: 21490602
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Perspectives on somatic reprogramming: spotlighting epigenetic regulation and cellular heterogeneity.
    Chen J
    Curr Opin Genet Dev; 2020 Oct; 64():21-25. PubMed ID: 32599300
    [TBL] [Abstract][Full Text] [Related]  

  • 15. EMT and MET as paradigms for cell fate switching.
    Chen J; Han Q; Pei D
    J Mol Cell Biol; 2012 Apr; 4(2):66-9. PubMed ID: 22140271
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The mesenchymal-to-epithelial transition in somatic cell reprogramming.
    Esteban MA; Bao X; Zhuang Q; Zhou T; Qin B; Pei D
    Curr Opin Genet Dev; 2012 Oct; 22(5):423-8. PubMed ID: 23084025
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Partially Reprogrammed Induced Pluripotent Stem Cells Using MicroRNA Cluster miR-302s in Guangxi Bama Minipig Fibroblasts.
    Qiao S; Deng Y; Li S; Yang X; Shi D; Li X
    Cell Reprogram; 2019 Oct; 21(5):229-237. PubMed ID: 31479283
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Stiffness of Hydrogels Regulates Cellular Reprogramming Efficiency Through Mesenchymal-to-Epithelial Transition and Stemness Markers.
    Choi B; Park KS; Kim JH; Ko KW; Kim JS; Han DK; Lee SH
    Macromol Biosci; 2016 Feb; 16(2):199-206. PubMed ID: 26439948
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The epithelial-mesenchymal transition factor SNAIL paradoxically enhances reprogramming.
    Unternaehrer JJ; Zhao R; Kim K; Cesana M; Powers JT; Ratanasirintrawoot S; Onder T; Shibue T; Weinberg RA; Daley GQ
    Stem Cell Reports; 2014 Nov; 3(5):691-8. PubMed ID: 25316190
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Epigenetics of cellular reprogramming.
    Krishnakumar R; Blelloch RH
    Curr Opin Genet Dev; 2013 Oct; 23(5):548-55. PubMed ID: 23948105
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.